Designed to empower clinicians towards personalizing pain management, OpalGenix is commercializing GPS-Opioid, an opioid risk prediction and decision support tool. Use and availability of the resource is intended to enable the clinician in the process of opioid selection, dosing and prescribing to maximize pain relief while minimizing the likelihood of costly adverse events and the taking of safety risks.
